Navigation Links
Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
Date:7/28/2011

SAN DIEGO, July 28, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) today confirmed that the U.S. Food and Drug Administration (FDA) approved dosing recommendations for OFIRMEV® (acetaminophen) injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg.

Cadence's announcement follows the issuance of a news release by a major manufacturer of over-the-counter (OTC) acetaminophen products announcing its plans to lower the recommended maximum daily dose of some oral acetaminophen products in an effort to reduce the risk of accidental acetaminophen overdose among consumers in the OTC setting.  

"We believe it is important that healthcare providers know that the new recommended dosing guidelines for the OTC products do not affect the recommended dosing guidelines for OFIRMEV," said James Breitmeyer, M.D., Ph.D., Chief Medical Officer of Cadence Pharmaceuticals. "The safety and effectiveness of OFIRMEV at 4,000 mg per day has been well established in numerous clinical trials and is supported by extensive experience with the drug in Europe, where it has been the foundation of IV pain management since its introduction in 2002. Healthcare professionals should continue to administer OFIRMEV as recommended in the FDA-approved package insert."

About OFIRMEV® (acetaminophen) Injection (1000 mg / 100 mL, 10 mg / mL)OFIRMEV (acetaminophen) injection, Cadence Pharmaceuticals' proprietary intravenous formulation of acetaminophen, is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. The FDA approval of OFIRMEV was based on data from clinical trials in approximately 1,020 adult and 355 pediatric patients. These trials included two studies evaluating the safety and effectiveness of OFIRMEV in the tr
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011
2. Cadence, Inc. Announces Major Expansion
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2011 Financial Results on May 5, 2011
4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2011
5. Cadence, Inc. Expands Executive Team
6. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
7. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
8. Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011
9. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
10. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
11. Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 Contego Medical, ... Embolic Protection™ filter platform for angioplasty balloon and ... $5.6 million Series B financing round led by ... with a focus on medical devices, biopharmaceuticals, diagnostics ... also included Mountain Group Partners, Lookout Capital and ...
(Date:4/17/2015)... MINNEAPOLIS , April 17, 2015 Nonin ... announced that President and Chief Operating Officer Steve ... Philip Isaacson is expanding his role as Chief ... his role as Chief Technology Officer. Operations will transition ... " Steve Bucholz has been instrumental to ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ) has announced ... Strategic Business Report" report to their offering. ... Testing in US$ Million by the following Segments: Toxicology ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ...
Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2
... Reportlinker.com announces that a new market ... Depression Therapeutics - Pipeline ... http://www.reportlinker.com/p0656880/Depression-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... Forecasts to 2018 Summary ...
... LAKE, N.J., Oct. 14, 2011 Par Pharmaceutical, Inc., ... PRX ) today announced that it filed ... injunction in U.S. District Court in Washington, D.C. seeking ... information to physicians and other healthcare providers about the ...
Cached Medicine Technology:Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 2Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 3Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 4Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 5Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 6Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 7Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 8Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 9Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 10Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 2Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 3Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 4
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining ... , Clients can review important auto insurance quotes ... provides important advantages for clients who need affordable financial ... not have coverage for their vehicles can purchase a ... hour. Many agencies offer important discounts and drivers can ...
(Date:4/18/2015)... Patients who undergo radiation for a ... in life, but the disease is likely to differ ... to radiation. Surviving Mesothelioma has just posted the details ... here to read it now. , Scientists from ... 45 patients who had both a hematologic cancer (like ...
(Date:4/18/2015)... More than 2000 styles of newly designed prom dresses ... store carrying celebrity inspired special occasion dresses. With the ... dresses for their prom. For those who are still ... would be an ideal choice. , "We have ... by the most loved styles seen at this years ...
(Date:4/18/2015)... April 18, 2015 “ ArcAngel ” was ... takes a look at the latest and coolest ... Troohey, the host of AppWatch and technology expert, conducted the ... personal safety app. , In a turbulent world, people ... Calling 911 should always be their first move, but some ...
(Date:4/17/2015)... 18, 2015 Heritage Woods of McLeansboro, ... Supportive Living Week Celebration on April 20 with a ... healthy mind, body and soul. , The community, which ... serves older adults of all incomes, including those on ... , Supportive Living Week is observed every April and ...
Breaking Medicine News(10 mins):Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... syndrome (BCS) results from hepatic venous outflow obstruction,at ... atrium. Few patients respond to,medical treatment (anticoagulation ... to restore the hepatic blood flow. Restoring outflow ... balloon dilatation stenting is the management of ...
... TUESDAY, March 15 (HealthDay News) -- Guidelines for children,s ... updated, say researchers who reviewed 69 studies that included ... produced new reference ranges that differ widely from existing ... University in the United Kingdom, and colleagues. The reference ...
... March 14 If all eligible patients filled their prescriptions ... amount to nearly $6 billion, according to a University of ... the March 14 issue of Archives of Internal Medicine ... national savings from a broad use of discounted generic medication ...
... Heavy alcohol consumption, specifically three or more glasses ... risk of death from pancreatic cancer, according to a ... of Internal Medicine, one of the JAMA/Archives journals. ... is causally related to several cancers, including oral ...
... HealthDay Reporter , MONDAY, March 14 (HealthDay ... breast cancer, tamoxifen can protect against the disease for ... medical costs, new research suggests. For years, women ... tamoxifen as a preventive measure. But previous cost-effectiveness research ...
... , MONDAY, March 14 (HealthDay News) -- Women may ... a diet rich in two types of B vitamins, a ... and riboflavin (B2) in their food significantly reduced their risk ... fortified cereals, whole grains, beans and nuts, and researchers said ...
Cached Medicine News:Health News:Updates Urged for Kids' Heart, Breathing Rate Guidelines 2Health News:Use of $4 generic drug programs could save society billions of dollars, study shows 2Health News:Heavy drinking associated with increased risk of death from pancreatic cancer 2Health News:Breast Cancer Drug Tamoxifen Saves Lives, Medical Costs: Study 2Health News:Breast Cancer Drug Tamoxifen Saves Lives, Medical Costs: Study 3Health News:Diets Rich in Vitamin B May Help Prevent PMS, Study Finds 2
... a number of assay steps for ... simple to use benchtop device. The ... stand-alone device but also provides easy ... and standard add-on modules provide maximum ...
... The AVOXimeter 4000 provides a fast, ... bedside. The AVOXimeters patented,state-of-the-art optics yield ... as well as total hemoglobin. When,used ... analyzer, the AVOXimeter,4000 gives a comprehensive ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
The IL 682 is the Gold Standard for CO-Oximetry analysis....
Medicine Products: